Home LiteratureArticle Details
PMID: 19305381 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis.

Hafkamp HC, Mooren JJ, Claessen SM, Klingenberg B, Voogd AC, Bot FJ, Klussmann JP, Hopman AH, Manni JJ, Kremer B, Ramaekers FC, Speel EJ

Abstract

Human papillomavirus is involved in the carcinogenesis of tonsillar squamous cell carcinomas. Here, we investigated the expression and the prognostic value of key cell cycle proteins in the pRb and p53 pathways in both human papillomavirus type 16-positive and -negative tonsillar squamous cell carcinomas. Using immunohistochemistry, 77 tonsillar squamous cell carcinomas with known human papillomavirus type 16 status and clinical outcome were analyzed for expression of Ki67, p16(INK4A,) cyclin D1, pRb, p14(ARF), MDM2, p53, p21(Cip1/WAF1), and p27(KIP1). Results were correlated with each other and with clinical and demographic patient data. A total of 35% of tonsillar carcinomas harbored integrated human papillomavirus type 16 DNA and p16(INK4A) overexpression, both being considered essential features for human papillomavirus association. These tumors also showed the overexpression of p14(ARF) (P<0.0001) and p21(Cip1/WAF1) (P=0.001), and downregulation of pRb (P<0.0001) and cyclin D1 (P=0.027) compared with the human papillomavirus-negative cases. Univariate Cox regression analyses revealed a favorable survival rate for non-smokers (P=0.006), as well as for patients with T1-2 tumors (P<0.0001) or tumors showing low expression of cyclin D1 (P=0.028), presence of human papillomavirus and overexpression of p16(INK4A) (P=0.01), p14(ARF) (P=0.02) or p21(Cip1/WAF1) (P=0.004). In multivariate regression analyses, smoking and tumor size, as well as expression of cyclin D1 and p21(Cip1/WAF1), were found to be independent prognostic markers. We conclude that human papillomavirus positivity in tonsillar squamous cell carcinomas strongly correlates with p21(Cip1/WAF1) and p14(ARF) overexpression and downregulation of pRb and cyclin D1. In particular p21(Cip1/WAF1) overexpression is an excellent favorable prognosticator in tonsillar squamous cell carcinomas.

MeSH Terms
Adult Aged Aged, 80 and over Biomarkers, Tumor/analysis Carcinoma, Squamous Cell/metabolism,mortality,virology Cell Cycle Proteins/biosynthesis Cyclin D1/biosynthesis Cyclin-Dependent Kinase Inhibitor p21/biosynthesis Female Gene Expression Humans Immunohistochemistry Kaplan-Meier Estimate Male Middle Aged Papillomaviridae Papillomavirus Infections/metabolism,mortality Prognosis Retinoblastoma Protein/biosynthesis Smoking/adverse effects Tonsillar Neoplasms/metabolism,mortality,virology Tumor Suppressor Protein p14ARF/biosynthesis
Chemicals
Biomarkers, Tumor CDKN1A protein, human Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p21 Retinoblastoma Protein Tumor Suppressor Protein p14ARF Cyclin D1
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Hafkamp Harriët C
Department of Otorhinolaryngology and Head and Neck Surgery, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
Mooren Jeroen J
Claessen Sandra M H
Klingenberg Boris
Voogd Adri C
Bot Fredrik J
Klussmann J Peter
Hopman Anton H N
Manni Johannes J
Kremer Bernd
Ramaekers Frans C S
Speel Ernst-Jan M
Article Info
Journal
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Abbr.
Mod Pathol
ISSN
1530-0285
Published
2009-05-00
Epub
2009-00-20
Pages
686-98
Language
English
Region
United States
NLM ID
8806605
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com